Filter
1285
Text search:
adverse
drug
event
Featured
176
319
Language
Document type
685
262
156
97
41
16
15
6
2
1
1
1
1
Countries / Regions
85
44
37
30
29
25
24
21
19
19
18
16
15
15
13
12
12
11
11
11
9
9
8
8
7
7
7
6
6
5
5
5
5
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
408
200
86
70
44
26
22
Toolboxes
141
136
87
70
65
56
44
32
30
27
22
19
18
16
15
14
12
11
11
8
7
6
5
3
1
Technical Brief
Therapeutics Information and Pharmacovigilance Centre | TIPC
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition
Joining efforts to control two trelated global epidemics.
The WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks.
Accessed November 2017
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
Patient Safety tutorial 325
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h
...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)
...
